Biopsy Diagnosis of Chronic Hepatitis - Results of an Evidence-Based Consensus Conference of the German Society of Pathology (DGP), the German Society for Digestive and Metabolic Diseases (DGVS), and the Network of Competence for Hepatitis (HepNet);Bioptische Diagnostik der Chronischen Hepatitis - Ergebnisse einer Evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Pathologie (DGP), der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und des Kompetenznetzes Hepatitis (HepNet)

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 2, 2004, Pages 175-185

  Schirmacher, P ^a   Fleig, W E ^a   Dienes, H P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Biopsy; Consensus; Grading; Hepatitis; Liver; Staging

Indexed keywords

CHRONIC HEPATITIS; COMPETENCE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; LIVER BIOPSY; MEDICAL SOCIETY;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; PROGNOSIS;

EID: 1442277002     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812728     Document Type: Conference Paper

References (29)

1. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999; 30: 956-961 (IV)
2. Hopf U, Niederau C, Kleber G et al. Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 1997; 35: 971-986 (IV)
3. National Institutes of Health consensus development conference statement. Management of hepatitis C: 2002. Hepatology 2002; 36: S3-S20 (IV)
4. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938 (IV)
5. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36: S152-S160 (IV)
6. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36: S47-S56 (IV)
7. Pradat P, Poynard T, Alberti A et al. Predictive value of ALT levels for histologic findings in chronic Hepatitis C: a European collaborative study. Hepatology 2002; 36: 973-977 (III)
8. Gebo KA, Herlong HF, Torbenson MS. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36: S161-S172 (III)
9. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: A quantitative reference standard. Hepatology 1998; 28: 323-331 (IIb)
10. Piccinino F, Sagnelli E, Pasquale G et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-173 (III)
11. Miniuk GY, Sutherland LR, Wiseman DA et al. Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bedrest after percutaneous liver biopsy. Gastroenterology 1987; 92: 290-293 (Ib)
12. Hederström E, Forsberg L, Florén CH et al. Liver biopsy complications monitored by ultrasound. J Hepatol 1989; 8: 94-98 (IV)
13. McGill DB, Rakela J, Zinsmeister AR et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-1400 (IIa)
14. Conn HO. Liver biopsy: increased risks in patients with cancer. Hepatology 1991; 14: 206-209 (III)
15. Gordon SC, Veneri RJ, McFadden RF et al. Major hemorrhage after percutaneous liver biopsy in patients with AIDS. Gastroenterology 1991; 100: 1787 (IV)
16. Özdogan M, Özgür O, Boyacioglu S et al. Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 1996; 74: 442-444 (III)
17. Terjung B, Lemnitzer I, Dumoulin FL et al. Bleeding complications after percutaneous liver biopsy: an analysis of risk factors. Digestion 2003; 67: 138-145 (III)
18. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45 (Suppl. IV): 1-11 (IV)
19. Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520 (IV)
20. Batts KP, Ludwig J. Chronic hepatitis - an update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417 (IV)
21. Ishak KG, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699 (IV)
22. Bedossa P, Poynard T for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293 (III)
23. De Groote J, Desmet V, Gedigk P et al. A classification of chronic hepatitis. Lancet 1968; ii: 626-628
24. Goldin RD, Goldin JG, Burt AD et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649-654 (III)
25. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
26. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374 (IV)
27. The METAVIR Cooperative Group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20: 15-20 (III)
28. Chevallier M, Guerret S, Chossegros P et al. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20: 349-355 (IIb)
29. Dries V, von Both I, Müller M et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 1999; 29: 223-229 (IIb)